Latest News about MRK
Recent news which mentions MRK
3 Stocks That Could Turn $1,000 into $5,000 by 2030
December 20, 2024
From Motley Fool
Merck's Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials
December 19, 2024
From Benzinga
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
December 19, 2024
From Benzinga
Stock Of The Day: Where Does The Merck Downtrend End?
December 19, 2024
From Benzinga
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
December 18, 2024
From Benzinga
What's Going On With Viking Therapeutics Stock On Wednesday?
December 18, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 18, 2024
From Benzinga
What's Going On With Merck Shares Wednesday?
December 18, 2024
From Benzinga
From Benzinga
From Benzinga
Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients
December 13, 2024
From Benzinga
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
December 12, 2024
From Motley Fool
AstraZeneca-Merck Partnered Lynparza Shows Long-Term Survival With Reduced Death Risk Of 28% In Breast Cancer Patients
December 11, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 10, 2024
From Benzinga
Merck Reveals Mixed Data From Keytruda/Lynparza Regime In Ovarian Cancer
December 09, 2024
From Benzinga
2 Healthcare Dividend Stocks to Hold for the Long Haul
December 07, 2024
From Motley Fool
Why Summit Therapeutics Stock Rocketed 6% Higher on Friday
December 06, 2024
From Motley Fool
This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy?
December 05, 2024
From Motley Fool
3 Ultra-Cheap Dividend Stocks to Buy in December
December 05, 2024
From Motley Fool
From Benzinga
The Smartest Dividend Stocks to Buy With $3,000 Right Now
November 28, 2024
From Motley Fool
Why Is Merck Stock Trading Higher On Monday?
November 25, 2024
From Benzinga
Pyxis Oncology's Cancer Drug Progress Stirs Analyst Concerns
November 21, 2024
From Benzinga
2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist
November 21, 2024
From Motley Fool
Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
November 19, 2024
From Benzinga
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
November 15, 2024
From Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
November 15, 2024
From Benzinga
Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial
November 14, 2024
From Benzinga
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.